Atlas Trials

Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence

Clinical trial NCT04186845 · COMPLETED

Trial details

NCT number
NCT04186845
Sponsor
Blue Earth Diagnostics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2020-05-04
Primary completion
2021-04-28
Enrollment
391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.